The DCI Prostate & Urologic Cancer Center provides comprehensive patient care and education, professional training, and cutting-edge clinical, translational, and population research. Our team includes urologists, medical oncologists, radiation oncologists, a dedicated genitourinary (GU) radiology and pathology group, nurse practitioners, physician assistants, scientists, and pathologists. The Center’s priorities are to:
- Promising new treatment through prostate cancer clinical trials
- Leading studies to better understand patient factors that affect the most aggressive forms of prostate cancer
- Develop new strategies to target the immune system
- Conduct population studies in prostate cancer screening to empower patients and lower the burden of disease
- Inspire and support careers of junior faculty and trainees to become the next generation of clinical and research leaders in the field.
At Duke Prostate and Urologic Cancer Center, we’ve put together a team of rising stars and world-renowned physicians specializing in managing patients with all types of urologic cancers — from both common and unusual cases of:
- Prostate cancer
- Kidney cancer
- Bladder cancer
- Testicular cancer
- Upper tract urothelial cancers
- Mediastinal germ cell cancers
- Pagets disease of the scrotum
- Penile cancer
- Stromal tumors of the testis
- Small cell/Neuroendocrine cancer of the prostate or bladder
- Teratoma
- Urethral cancer
- Urachal cancer
